BLINKLAB LIMITED — Investor Relations & Filings

BlinkLab Limited is a digital health technology company specializing in the development of smartphone-based diagnostic platforms for neurodevelopmental and neurodegenerative disorders. The company utilizes advanced computer vision and machine learning algorithms to transform standard smartphones into clinical-grade tools for neurological assessment. Its core technology focuses on the eyeblink conditioning paradigm, a well-established biomarker for brain function, to screen for conditions such as Autism Spectrum Disorder (ASD), ADHD, and schizophrenia. By enabling remote, objective, and scalable testing, BlinkLab aims to facilitate early intervention and continuous monitoring outside of traditional clinical settings. The platform is designed to provide healthcare professionals with data-driven insights to improve diagnostic accuracy and patient outcomes in the field of behavioral health and neurology.